Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
2.730
0.00 (0.00%)
At close: May 23, 2025, 4:00 PM
2.645
-0.085 (-3.11%)
After-hours: May 23, 2025, 4:26 PM EDT

Orchestra BioMed Holdings Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-66.32-61.02-49.12-33.61-23.01-21.36
Depreciation & Amortization
0.320.310.290.220.180.14
Other Amortization
0.080.030.110.160.22-
Asset Writedown & Restructuring Costs
1.051.05----
Loss (Gain) From Sale of Investments
-1-1.43-3.8-1.630.292.93
Stock-Based Compensation
10.9910.627.633.410.30.22
Other Operating Activities
0.750.672.082.6-0.030.07
Change in Accounts Receivable
-0.010.02-00.030.05-0.08
Change in Inventory
-0.02-0.030.13-0.210-0.03
Change in Accounts Payable
4.042.970.153.351.08-2.61
Change in Unearned Revenue
-2.24-2.01-2.11-2.861.48-5.17
Change in Other Net Operating Assets
-1.7-1.72-1.47-0.760.03-0.31
Operating Cash Flow
-54.06-50.56-46.13-29.29-19.43-26.18
Capital Expenditures
-0.39-0.29-0.08-0.59-0.27-0.54
Cash Acquisitions
-0.6-0.6----
Investment in Securities
21.2213.9810.77-63.5313.527.69
Other Investing Activities
-----0.21-0.19
Investing Cash Flow
20.2313.0910.69-64.1213.0226.97
Long-Term Debt Issued
-15-10-10
Long-Term Debt Repaid
---10.85-6.45-4-
Net Debt Issued (Repaid)
1515-10.853.55-410
Issuance of Common Stock
15.3515.280.250.20.01-
Repurchase of Common Stock
-0.94-0.55----
Other Financing Activities
-0.55-0.5556.81-10.33--
Financing Cash Flow
28.8629.1746.22103.26-3.9910
Net Cash Flow
-4.98-8.310.789.85-10.4110.78
Free Cash Flow
-54.45-50.85-46.21-29.88-19.7-26.72
Free Cash Flow Margin
-1886.80%-1927.48%-1674.09%-845.74%--468.56%
Free Cash Flow Per Share
-1.46-1.38-1.39-1.99-9.33-13.27
Cash Interest Paid
0.460.11.121.370.39-
Levered Free Cash Flow
-28.16-25.45-33.04-10.06-13.86-
Unlevered Free Cash Flow
-27.76-25.3-32.28-10.22-13.5-
Change in Net Working Capital
-4.32-4.267.92-7.150.08-
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q